Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $137.6200 (1.93%) ($134.6400 - $137.8800) on Wed. Jul. 5, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.48% (three month average) | RSI | 46 | Latest Price | $137.6200(1.93%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV advances 0.8% a day on average for past five trading days. | Weekly Trend | ABBV declines -1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(54%) SPLV(43%) DIA(38%) IBB(36%) VYM(36%) | Factors Impacting ABBV price | ABBV will decline at least -0.74% in a week (0% probabilities). VXX(-19%) SLV(-18%) VIXM(-17%) GDXJ(-15%) GDX(-15%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.74% (StdDev 1.48%) | Hourly BBV | 1.6 () | Intraday Trend | 1.8% | | | |
|
5 Day Moving Average | $134.62(2.23%) | 10 Day Moving Average | $135.06(1.9%) | 20 Day Moving Average | $136.1(1.12%) | To recent high | -16.5% | To recent low | 3.9% | Market Cap | $242.801b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |